A case report of persistent drug-sensitive pulmonary tuberculosis after treatment completion

[1] Dorman S(2021)Four-month rifapentine regimens with or without moxifloxacin for tuberculosis N Engl J Med 384 1705-1718

[2] Nahid P(2018)A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis Nat Med 24 1708-1715

[3] Kurbatova E(2019)Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis Int J Infect Dis 82 66-72

[4] Phillips P(2016)The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis BMC Infect Dis 16 262-1100

[5] Bryant K(2016)Persisting positron emission tomography lesion activity and Nat Med 22 1094-e195

[6] Dooley K(2016) mRNA after tuberculosis cure Clin Infect Dis 63 e147-1602

[7] Imperial M(2010)Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis Ann Thorac Surg 89 1597-453

[8] Nahid P(2001)Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis J Thorac Cardiovasc Surg 121 448-421

[9] Phillips P(2007)Pulmonary resection for multi-drug resistant tuberculosis Thorax 62 416-183

[10] Davies G(2009)Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru Eur Respir J 34 180-1645

[1] Dorman S(2021)Four-month rifapentine regimens with or without moxifloxacin for tuberculosis N Engl J Med 384 1705-1718

[2] Nahid P(2018)A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis Nat Med 24 1708-1715

[3] Kurbatova E(2019)Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis Int J Infect Dis 82 66-72

[4] Phillips P(2016)The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis BMC Infect Dis 16 262-1100

[5] Bryant K(2016)Persisting positron emission tomography lesion activity and Nat Med 22 1094-e195

[6] Dooley K(2016) mRNA after tuberculosis cure Clin Infect Dis 63 e147-1602

[7] Imperial M(2010)Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis Ann Thorac Surg 89 1597-453

[8] Nahid P(2001)Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis J Thorac Cardiovasc Surg 121 448-421

[9] Phillips P(2007)Pulmonary resection for multi-drug resistant tuberculosis Thorax 62 416-183

[10] Davies G(2009)Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru Eur Respir J 34 180-1645